Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
Adopted 503 for · 57 against · 108 abstentions · 51 did not vote
Details
The whole chamber
Seating as in the European Parliament chamber, in this order: The Left, S&D, Greens/EFA, Renew, EPP, ECR, PfE, ESN and the non-attached members.
How each group voted
| Group | For | Abst. | Against | Did not vote | Cohesion |
|---|---|---|---|---|---|
| EPP | 176 | 5 | 0 | 7 | 97% |
| S&D | 127 | 0 | 0 | 9 | 100% |
| PfE | 21 | 37 | 21 | 6 | 47% |
| ECR | 5 | 56 | 11 | 7 | 78% |
| Renew | 68 | 1 | 0 | 6 | 99% |
| Greens/EFA | 51 | 0 | 0 | 2 | 100% |
| The Left | 37 | 2 | 0 | 7 | 95% |
| ESN | 1 | 1 | 22 | 3 | 92% |
| NI | 17 | 6 | 3 | 4 | n/a |
Source: European Parliament roll-call votes, via HowTheyVote (ODbL). Collected 8 November 2026.
How each country voted
Click a country to see its MEPsSource: European Parliament roll-call votes, via HowTheyVote (ODbL). Collected 8 November 2026.
Winning majority
The winning side was For. Each group's position is the option chosen by most of its members who voted.
By country
About this vote
Reference: A10-0272/2025
Procedure: 2025/0102(COD)
Committee: SANT
20 January 2026, 12:51 · Strasbourg plenary
Other roll-call votes on this file: Proposal for rejection (amendment 258): rejected, 44 for · 600 against
Explanations of vote
MEPs who explained their vote orally in plenary, in the order they spoke.
- Dan BarnaRenew · RomaniaText and video →
- João OliveiraThe Left · PortugalText and video →
Verbatim report of the European Parliament. © European Union, 2026 - Source: European Parliament.
Method
Cohesion is the share of the group's voting members who followed the group position, the option chosen by most of them. Off the group line: an MEP who voted differently from their group's position. Prepared with AI tools and reviewed by a person before publishing. Report an error: radar@parleon.eu.